EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lipid nanoparticle-mediated drug delivery to the brain

Purva Khare, Sara X Edgecomb, Christine M Hamadani, Eden E L Tanner, Devika S Manickam

Advanced Drug Delivery Reviews · 2023-06 · 197 · 114861

DOI: 10.1016/j.addr.2023.114861 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-06. Verfasst von Purva Khare und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 190-mal zitiert (Crossref) und nennt 268 Literaturangaben. Gefördert von: Duquesne University, Office of Research, University of Kansas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have revolutionized the field of drug delivery through their applications in siRNA delivery to the liver (Onpattro) and their use in the Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines. While LNPs have been extensively studied for the delivery of RNA drugs to muscle and liver targets, their potential to deliver drugs to challenging tissue targets such as the brain remains underexplored. Multiple brain disorders currently lack safe and effective therapies and therefore repurposing LNPs could potentially be a game changer for improving drug delivery to cellular targets both at and across the blood-brain barrier (BBB). In this review, we will discuss (1) the rationale and factors involved in optimizing LNPs for brain delivery, (2) ionic liquid-coated LNPs as a potential approach for increasing LNP accumulation in the brain tissue and (3) considerations, open questions and potential opportunities in the development of LNPs for delivery to the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NanoparticlesHumansLipidsLiposomesRNA, Small InterferingBrain

Stichwörter der Autor:innen

Blood-brain barrierIonic liquidsIonizable cationic lipidLipid nanoparticlesRed blood cell hitchhiking

Substanzen

Lipid NanoparticlesLipidsLiposomesRNA, Small Interfering

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.
  • Department of Chemistry and Biochemistry, The University of Mississippi, MS, United States.
  • Department of Chemistry and Biochemistry, The University of Mississippi, MS, United States. Electronic address: eetanner@olemiss.edu.
  • Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States. Electronic address: soundaramanickd@duq.edu.

Förderung

  • Duquesne University
  • Office of Research, University of Kansas

Zitieren

APA

Khare, P., Edgecomb, S. X., Hamadani, C. M., Tanner, E. E. L., & S Manickam, D. (2023). Lipid nanoparticle-mediated drug delivery to the brain. Advanced Drug Delivery Reviews, 197, 114861. https://doi.org/10.1016/j.addr.2023.114861

Vancouver

Khare P, Edgecomb SX, Hamadani CM, Tanner EEL, S Manickam D. Lipid nanoparticle-mediated drug delivery to the brain. Advanced Drug Delivery Reviews. 2023;197:114861. doi:10.1016/j.addr.2023.114861

BibTeX
@article{Khare2023,
  author = {Khare, Purva and Edgecomb, Sara X and Hamadani, Christine M and Tanner, Eden E L and S Manickam, Devika},
  title = {Lipid nanoparticle-mediated drug delivery to the brain},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  volume = {197},
  pages = {114861},
  doi = {10.1016/j.addr.2023.114861}
}
Kostenlos starten →